BioShield Technologies Inc. Announces Appointment of Senior Officers.

NORCROSS, Ga.--(BUSINESS WIRE)--Nov. 19, 1998--BioShield Technologies Inc. (Nasdaq:BSTIU) Thursday announced the appointments of Jeffrey A. Parker as COO and vice president of Sales and Marketing, and Daniel E. Swaye, CPA, as chief financial officer.

Commenting on the appointments, Co-Chairman, President and CEO Timothy Moses said: "Parker brings a wealth of experience to BioShield. His proven track record as a turn around specialist, together with his management and marketing expertise, conforms with our objective of taking BioShield from the emerging development stage to becoming a profitable company."

Prior to joining BioShield, Parker was president and CEO of Crider Inc., and Crider Poultry Inc., taking them from losses in 1995 to profitability in 1997. He served as VP and general manager of Foster Farms from 1992 to 1995 where he increased revenues to $16.1 million during that period.

In 1989 he was the youngest president and CEO appointed to Bryan Foods, a division of Sara Lee Corp. and had achieved record profits by 1991. Parker also has significant executive management, marketing and brand management experience with Con Agra, Schering Plough and Oscar Mayer Foods.

Parker's roles at BioShield will include brand development, development of pricing strategies and cultivation of revenue generating alliances with institutional and mass merchandising customers.

Moses went on to say: "We are also delighted to have recruited Daniel Swaye for the position of CFO. Swaye's understanding of the financial dynamics of a company, combined with his merger and acquisition experience, will be vital to our continued growth and profitability.

"Swaye is a very credible, straightforward person who will give realistic numbers and evaluate our mergers and acquisitions from a position of strength so that we can add earnings to our bottom line."

Swaye served as corporate controller of Atlanta-based AVL Scientific Corp., a medical equipment manufacturer with $37 million in sales, prior to joining BioShield. He also worked with Delta International Manufacturing, Dental One, Scientific Atlanta, US Specialty Retaining and Arthur Andersen.

Swaye's roles at BioShield will include management of all financial, treasury and accounting functions as well as investor relations.

BioShield Technologies develops and markets antimicrobial and biostatic products for retail sale and for use in the industrial, environmental and medical markets.

Statements in this news release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including, but not limited to, risks and uncertainties related to new developing technologies, dependence on collaborative partners, the inherent complexity and uncertainty regarding the development of products, BioShield's early-stage development, the result of research and development efforts, future capital needs, and the uncertainty of additional funding and government regulations and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof.